Sharon G. Gregorcyk, M.D.

NPI 1982647806ActiveIndividual· Colon & Rectal Surgery· Dallas, TX

Colon & Rectal Surgery (M.D.) in Dallas, Texas, trained at University of Texas Southwestern Medical School at Dallas (class of 1991). 262 Medicare patients in 2024, $63,654 paid; nearly all of their 104 Part D prescriptions were generic (91%). Myriad Genetic Laboratories, Inc. was the largest of 3 companies reporting payments in 2025, $66.95 in all, mostly food and beverage.

Overview

NPI	1982647806
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jun 14, 2006
Last updated in NPPES	Mar 25, 2021
Certified by provider	Mar 25, 2021

Specialties and licenses

Taxonomy	Code	License	State
Colon & Rectal Surgery Primary	208C00000X	K7546	TX

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Colorectal Surgery (Proctology) (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	262
Services billed	489 across 49 procedure codes
Paid by Medicare	$63,654

Part D prescriptions in 2024

Prescriptions (claims)	104 · 112 30-day fills
Patients	53
Total drug cost	$4,799
Generic share	91% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Southwestern Medical School at Dallas
Graduation year	1991
Medicare specialty	Colorectal Surgery (Proctology)
Telehealth	Offers telehealth